Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,670.00
+71.00 (4.44%)
At close: Feb 13, 2026
Market Cap15.49B +41.8%
Revenue (ttm)1.00B
Net Income-13.37B
EPS-1,637.42
Shares Out9.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,384
Average Volume9,824
Open1,700.00
Previous Close1,599.00
Day's Range1,402.00 - 1,700.00
52-Week Range680.00 - 3,300.00
Beta-0.06
RSI36.64
Earnings Daten/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops therapeutic drugs for non-alcoholic liver disease treatment and the anticancer field. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements